At the completion of this activity, the participant will be able to:
1. Examine the pharmacokinetics and pharmacodynamics of available oral P2Y12 inhibitors and the clinical implications
2. Compare the European and American guidelines for duration of DAPT for patients undergoing Percutaneous Coronary Intervention (PCI) for Chronic Coronary Disease (CCD) or Acute Coronary Syndrome (ACS)
3. Analyze recently published peer-reviewed literature regarding the duration of DAPT for patients undergoing PCI 
4. Demonstrate how to apply the guidelines and literature to clinical practice

Session date: 
10/21/2024 - 12:00pm to 1:00pm EDT
Location: 
AGH Lecture Hall (1st Floor South Tower) and on Zoom Webinar
To Join the Zoom Webinar:
https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454; Passcode: 877628
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.